Fig. 44.1 (a) Schematic drawing of constructed “J”-pouch (left) and “S”-pouch (right). (b) Normal-appearing J-pouch with efferent (top) and afferent (bottom) giving “owl’s eye” appearance. (c) Inflamed pouch with diffuse…
, Emily P. Whitfield2 , Jeremy Adler2 and Peter D. R. Higgins3 (1) Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA (2) Department of Pediatrics and Communicable Diseases, Pediatric Inflammatory Bowel Disease…
Obstruction Bleeding Perforation Fistula Phlegmon Abscess Drug allergies Drug resistance Perineal disease Urologic complications Progression Growth failure Fig. 41.1 Distribution of pediatric Crohn disease (de Bie et al. [10]) Isolated…
and Manu R. Sood2, 3 (1) Children’s Hospital Medical Center, Cincinnati, OH, USA (2) Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatric, Medical College of Wisconsin, Milwaukee, WI, USA (3)…
and Justin Vandergrift2 (1) Chapel Hill, North Carolina, USA (2) Charlotte, North Carolina, USA KeywordsSelf-managementAdherencePatient activationCo-production Introduction As chronic medical conditions, such as inflammatory bowel disease (IBD), predominate as a…
Fig. 23.1 Normal mucosal findings (a) in the mid-small bowel as seen by wireless capsule endoscopy in a child suspected of Crohn disease. The astonishing resolution of the capsule’s lens…
Fig. 2.1 The anatomy of the intestinal immune system. The basic organizational structure of the intestinal immune system. The follicular-associated epithelium (FAE) contains M (microfold) cells which transport antigen into…
Fig. 35.1 Drugs in pipeline for CD (Amiot and Peyrin-Biroulet [1]) Fig. 35.2 Drugs in pipeline for UC (Amiot and Peyrin-Biroulet [1]) Table 35.1 Treatments discussed in this chapter Target…
Fig. 15.1 Evaluation of child with suspected IBD. Atypical UC is a new IBD category consisting of 5 phenotypes and reflects a phenotype that should be treated as UC. IBD-U…
Drug Formulation Delivery system Dosage form Release location Azo-bonded formulations Sulfasalazine (Azulfidine®) Azo bond of 5-ASA to sulfapyridine Broken down by colonic bacteria to release active 5-ASA moiety Tablet 500…
